{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:25:49Z","timestamp":1790573149902,"version":"4.1.0"},"reference-count":238,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2022JH-RYFW-0062"],"award-info":[{"award-number":["2022JH-RYFW-0062"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2024CY-JJQ-52"],"award-info":[{"award-number":["2024CY-JJQ-52"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2024NCYBXM-100"],"award-info":[{"award-number":["2024NCYBXM-100"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2023-ZDLNY-17"],"award-info":[{"award-number":["2023-ZDLNY-17"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2024PT-ZCK-20"],"award-info":[{"award-number":["2024PT-ZCK-20"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2024CY-JJQ-73"],"award-info":[{"award-number":["2024CY-JJQ-73"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2024SF-GJHX-12"],"award-info":[{"award-number":["2024SF-GJHX-12"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011710","name":"Shaanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2023GXLH-079"],"award-info":[{"award-number":["2023GXLH-079"]}],"id":[{"id":"10.13039\/501100011710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008387","name":"Xi'an Municipal Bureau of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["S2024-YF-YBNY-0621"],"award-info":[{"award-number":["S2024-YF-YBNY-0621"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024SF-ZDCYL-03-25"],"award-info":[{"award-number":["2024SF-ZDCYL-03-25"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273268"],"award-info":[{"award-number":["52273268"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803784"],"award-info":[{"award-number":["81803784"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404584"],"award-info":[{"award-number":["82404584"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373843"],"award-info":[{"award-number":["82373843"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32200315"],"award-info":[{"award-number":["32200315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010228","name":"Natural Science Foundation of Shaanxi Provincial Department of Education","doi-asserted-by":"publisher","award":["23JC011"],"award-info":[{"award-number":["23JC011"]}],"id":[{"id":"10.13039\/501100010228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010228","name":"Natural Science Foundation of Shaanxi Provincial Department of Education","doi-asserted-by":"publisher","award":["21JP014"],"award-info":[{"award-number":["21JP014"]}],"id":[{"id":"10.13039\/501100010228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010228","name":"Natural Science Foundation of Shaanxi Provincial Department of Education","doi-asserted-by":"publisher","award":["22JC012"],"award-info":[{"award-number":["22JC012"]}],"id":[{"id":"10.13039\/501100010228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202108610175"],"award-info":[{"award-number":["202108610175"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022-QCYZH-033"],"award-info":[{"award-number":["2022-QCYZH-033"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022-SLRH-YQ-009"],"award-info":[{"award-number":["2022-SLRH-YQ-009"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022-QCYZH-032"],"award-info":[{"award-number":["2022-QCYZH-032"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016067","name":"Shaanxi Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["2022-QCYZH-013"],"award-info":[{"award-number":["2022-QCYZH-013"]}],"id":[{"id":"10.13039\/100016067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pharmthera.2025.108795","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T15:58:58Z","timestamp":1737129538000},"page":"108795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery"],"prefix":"10.1016","volume":"267","author":[{"given":"Lei","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2025.108795_bb0005","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1046\/j.1471-4159.1999.0722032.x","article-title":"Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs","volume":"72","author":"Abadji","year":"1999","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.slasd.2023.08.007","article-title":"Key aspects of modern GPCR drug discovery","volume":"29","author":"Addis","year":"2024","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0015","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal","year":"2007","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0020","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","article-title":"Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons","volume":"100","author":"Ahluwalia","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0025","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jnc.12115","article-title":"Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor","volume":"124","author":"Ahn","year":"2013","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0030","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M112.438804","article-title":"Distinct roles of beta-arrestin 1 and beta-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1)","volume":"288","author":"Ahn","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3389\/fncel.2019.00424","article-title":"The endocannabinoid system as a window into microglial biology and its relationship to autism","volume":"13","author":"Araujo","year":"2019","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0040","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ijo.2010.21","article-title":"A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: A high-dose study","volume":"34","author":"Aronne","year":"2010","journal-title":"International Journal of Obesity"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eplepsyres.2009.01.003","article-title":"Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB(1) agonist ACEA in the pentylenetetrazole-induced seizure in mice","volume":"84","author":"Bahremand","year":"2009","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/mol.112.080879","article-title":"CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity","volume":"83","author":"Baillie","year":"2013","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0055","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/35003583","article-title":"Cannabinoids control spasticity and tremor in a multiple sclerosis model","volume":"404","author":"Baker","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","article-title":"Endocannabinoids control spasticity in a multiple sclerosis model","volume":"15","author":"Baker","year":"2001","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1134\/S0006297921070038","article-title":"Noncanonical activity of endocannabinoids and their receptors in central and peripheral synapses","volume":"86","author":"Balezina","year":"2021","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0070","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acschemneuro.6b00137","article-title":"Pharmacology of Valinate and tert-Leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues","volume":"7","author":"Banister","year":"2016","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1073\/pnas.0710487105","article-title":"The genetic design of signaling cascades to record receptor activation","volume":"105","author":"Barnea","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0080","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apt.12673","article-title":"Review article: The endocannabinoid system in liver disease, a potential therapeutic target","volume":"39","author":"Basu","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ymeth.2015.08.018","article-title":"In vivo veritas, the next frontier for functionally selective GPCR ligands","volume":"92","author":"Beaulieu","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nn.2494","article-title":"Bimodal control of stimulated food intake by the endocannabinoid system","volume":"13","author":"Bellocchio","year":"2010","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0095","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1016\/S0021-9258(18)69009-X","article-title":"beta-adrenergic receptor kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation","volume":"263","author":"Benovic","year":"1988","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.drudis.2019.02.010","article-title":"Strategies for the discovery of biased GPCR ligands","volume":"24","author":"Bermudez","year":"2019","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0105","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","article-title":"The endocannabinoid system in normal and pathological brain ageing","volume":"367","author":"Bilkei-Gorzo","year":"2012","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0110","doi-asserted-by":"crossref","first-page":"15670","DOI":"10.1073\/pnas.0504640102","article-title":"Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors","volume":"102","author":"Bilkei-Gorzo","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0115","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB(1) cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Blazquez","year":"2015","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-2914-6_12","article-title":"Approaches to assess functional selectivity in GPCRs: Evaluating G protein signaling in an endogenous environment","volume":"1335","author":"Bohn","year":"2015","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00005344-200304000-00020","article-title":"Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle","volume":"41","author":"Bonz","year":"2003","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1042\/bj3120637","article-title":"Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1","volume":"312","author":"Bouaboula","year":"1995","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/PMC.S32171","article-title":"The structure-function relationships of classical cannabinoids: CB1\/CB2 modulation","volume":"8","author":"Bow","year":"2016","journal-title":"Perspectives in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/10799893.2014.1003659","article-title":"The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice","volume":"35","author":"Breivogel","year":"2015","journal-title":"Journal of Receptor and Signal Transduction Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/cb800116f","article-title":"G-protein-coupled receptors: From classical modes of modulation to allosteric mechanisms","volume":"3","author":"Bridges","year":"2008","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB(1) receptor signaling in the brain: Extracting specificity from ubiquity","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0160","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.neuropharm.2016.08.002","article-title":"Cannabinoid-induced depression of synaptic transmission is switched to stimulation when dopaminergic tone is increased in the globus pallidus of the rodent","volume":"110","author":"Caballero-Floran","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0165","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/jop.2017.0037","article-title":"The In vivo effects of the CB(1)-positive allosteric modulator GAT229 on intraocular pressure in ocular normotensive and hypertensive mice","volume":"33","author":"Cairns","year":"2017","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0170","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1124\/jpet.107.125666","article-title":"Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys","volume":"323","author":"Cao","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0175","doi-asserted-by":"crossref","first-page":"27971","DOI":"10.1074\/jbc.M111.224352","article-title":"Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes","volume":"286","author":"Chanda","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0180","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrd746","article-title":"Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery","volume":"1","author":"Christopoulos","year":"2002","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB(1)R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0190","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/adt.2010.0347","article-title":"Dynamic mass redistribution as a means to measure and differentiate signaling via opioid and cannabinoid receptors","volume":"9","author":"Codd","year":"2011","journal-title":"Assay and Drug Development Technologies"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0195","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/oby.24019","article-title":"Seventeen years since rimonabant\u2019s downfall: Reassessing its suicidality risk profile","volume":"32","author":"Cohen","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0200","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0022-3565(25)10448-5","article-title":"Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol","volume":"263","author":"Compton","year":"1992","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12974-021-02354-1","article-title":"Neuroinflammation as an etiological trigger for depression comorbid with inflammatory bowel disease","volume":"19","author":"Craig","year":"2022","journal-title":"Journal of Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neuropharm.2007.06.005","article-title":"Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1\/2 MAP kinase signaling","volume":"54","author":"Daigle","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0225","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1124\/mol.115.103176","article-title":"Mechanisms of biased beta-Arrestin-mediated signaling downstream from the cannabinoid 1 receptor","volume":"89","author":"Delgado-Peraza","year":"2016","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0230","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00333.x","article-title":"Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus","volume":"77","author":"Derkinderen","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0235","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2009.197","article-title":"CB1 antagonists for obesity--what lessons have we learned from rimonabant?","volume":"5","author":"Di Marzo","year":"2009","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased Agonism of three different cannabinoid receptor agonists in mouse brain cortex","volume":"7","author":"Diez-Alarcia","year":"2016","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.mcb.2015.11.001","article-title":"Tango assay for ligand-induced GPCR-beta-arrestin2 interaction: Application in drug discovery","volume":"132","author":"Dogra","year":"2016","journal-title":"Methods in Cell Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.55782\/ane-2014-1985","article-title":"Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet","volume":"74","author":"Donat","year":"2014","journal-title":"Acta Neurobiologiae Experimentalis (Wars)"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0255","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuroscience.2010.06.056","article-title":"Behavioural and molecular consequences of chronic cannabinoid treatment in Huntington\u2019s disease transgenic mice","volume":"170","author":"Dowie","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0260","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bjp.0705464","article-title":"Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons","volume":"140","author":"Downer","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0265","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/wps.21075","article-title":"Cannabis, cannabinoids and psychosis: A balanced view","volume":"22","author":"D\u2019Souza","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0270","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1476-5381.2011.01444.x","article-title":"Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-gamma","volume":"163","author":"Du","year":"2011","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0275","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.1038\/s41598-024-58845-7","article-title":"Hexahydrocannabinol (HHC) and Delta(9)-tetrahydrocannabinol (Delta(9)-THC) driven activation of cannabinoid receptor 1 results in biased intracellular signaling","volume":"14","author":"Durydivka","year":"2024","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0280","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1016\/j.febslet.2005.10.019","article-title":"Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells","volume":"579","author":"Fang","year":"2005","journal-title":"FEBS Letters"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0285","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nbd.2004.10.015","article-title":"Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism","volume":"18","author":"Fernandez-Espejo","year":"2005","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0290","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1111\/bph.13866","article-title":"Galpha(s) signalling of the CB(1) receptor and the influence of receptor number","volume":"174","author":"Finlay","year":"2017","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0295","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/bph.14988","article-title":"100 years of modelling ligand-receptor binding and response: A focus on GPCRs","volume":"177","author":"Finlay","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0300","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/acschemneuro.9b00429","article-title":"Do toxic synthetic cannabinoid receptor agonists have signature in vitro activity profiles? A case study of AMB-FUBINACA","volume":"10","author":"Finlay","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0305","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0028-3908(03)00235-1","article-title":"Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats","volume":"45","author":"Finn","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0310","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/jpet.106.118737","article-title":"Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents","volume":"321","author":"Fong","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0315","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s43032-021-00588-1","article-title":"Cannabis and cannabinoids in reproduction and fertility: Where we stand","volume":"29","author":"Fonseca","year":"2022","journal-title":"Reproductive Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0320","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.phrs.2017.08.008","article-title":"Characterization of structurally novel G protein biased CB(1) agonists: Implications for drug development","volume":"125","author":"Ford","year":"2017","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0325","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/mds.10289","article-title":"Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson\u2019s disease","volume":"17","author":"Fox","year":"2002","journal-title":"Movement Disorders"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejphar.2014.05.007","article-title":"Characterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs","volume":"737","author":"Franks","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0335","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1021\/acs.jmedchem.1c00040","article-title":"Discovery of a biased allosteric modulator for cannabinoid 1 receptor: Preclinical anti-Glaucoma efficacy","volume":"64","author":"Garai","year":"2021","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0340","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/17460440902992870","article-title":"An overview of cell phenotypes in HCS: Limitations and advantages","volume":"4","author":"Gasparri","year":"2009","journal-title":"Expert Opinion on Drug Discovery"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0345","doi-asserted-by":"crossref","first-page":"7758","DOI":"10.1021\/jm501042u","article-title":"Diarylureas as allosteric modulators of the cannabinoid CB1 receptor: Structure-activity relationship studies on 1-(4-chlorophenyl)-3-3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenylurea (PSNCBAM-1)","volume":"57","author":"German","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0350","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0306-4522(93)90352-G","article-title":"Loss of cannabinoid receptors in the substantia nigra in Huntington\u2019s disease","volume":"56","author":"Glass","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0355","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: Evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0360","first-page":"1362","article-title":"Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors","volume":"56","author":"Glass","year":"1999","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0083-6729(09)81004-2","article-title":"Anandamide receptor signal transduction","volume":"81","author":"Goodfellow","year":"2009","journal-title":"Vitamins and Hormones"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0370","doi-asserted-by":"crossref","first-page":"29085","DOI":"10.1074\/jbc.M602516200","article-title":"Induction of Krox-24 by endogenous cannabinoid type 1 receptors in Neuro2A cells is mediated by the MEK-ERK MAPK pathway and is suppressed by the phosphatidylinositol 3-kinase pathway","volume":"281","author":"Graham","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0375","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1074\/jbc.M109.094011","article-title":"Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias","volume":"285","author":"Gregory","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0380","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","article-title":"The endocannabinoid system and pain","volume":"8","author":"Guindon","year":"2009","journal-title":"CNS & Neurological Disorders Drug Targets"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0385","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mce.2013.03.013","article-title":"Differential beta-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor","volume":"372","author":"Gyombolai","year":"2013","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.fbp.0000135704.56422.40","article-title":"CB1 cannabinoid receptors mediate anxiolytic effects: Convergent genetic and pharmacological evidence with CB1-specific agents","volume":"15","author":"Haller","year":"2004","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0395","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1087057105275344","article-title":"High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay","volume":"10","author":"Hamdan","year":"2005","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0400","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.3390\/ijms21207693","article-title":"Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory diseases","volume":"21","author":"Haspula","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0405","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(95)11289-9","article-title":"Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes","volume":"186","author":"Henry","year":"1995","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0410","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/15563650.2017.1393082","article-title":"Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA","volume":"56","author":"Hermanns-Clausen","year":"2018","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0415","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","article-title":"The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain","volume":"221","author":"Herzberg","year":"1997","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0420","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0306-4522(98)00524-7","article-title":"Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: A double-label in situ hybridization study","volume":"90","author":"Hohmann","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0425","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/sj.bjp.0707347","article-title":"PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats","volume":"152","author":"Horswill","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0430","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0028-3908(87)90035-9","article-title":"Cannabinoid inhibition of adenylate cyclase: Relative activity of constituents and metabolites of marihuana","volume":"26","author":"Howlett","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0435","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/3-540-26573-2_2","article-title":"Cannabinoid receptor signaling","volume":"168","author":"Howlett","year":"2005","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0440","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1046\/j.1471-4159.2000.0742174.x","article-title":"Azido- and isothiocyanato-substituted aryl pyrazoles bind covalently to the CB1 cannabinoid receptor and impair signal transduction","volume":"74","author":"Howlett","year":"2000","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106236","article-title":"Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists","volume":"130","author":"Hsiao","year":"2023","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0450","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/dom.12447","article-title":"A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis","volume":"17","author":"Hsiao","year":"2015","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0455","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB(1)","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0460","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","article-title":"Crystal structure of the human cannabinoid receptor CB(1)","volume":"167","author":"Hua","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0465","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-1953-1","article-title":"Structure of the neurotensin receptor 1 in complex with beta-arrestin 1","volume":"579","author":"Huang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.109.060251","article-title":"Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor","volume":"77","author":"Hudson","year":"2010","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0475","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/cmdc.201000246","article-title":"Discovery of 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist","volume":"5","author":"Hung","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0480","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acsmedchemlett.9b00256","article-title":"Identification of CB1 receptor allosteric sites using force-biased MMC simulated annealing and validation by structure-activity relationship studies","volume":"10","author":"Hurst","year":"2019","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0485","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0490","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41374-019-0327-5","article-title":"Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2","volume":"100","author":"Irungbam","year":"2020","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.118.112854","article-title":"Pyrimidinyl Biphenylureas act as allosteric modulators to activate cannabinoid receptor 1 and initiate beta-Arrestin-dependent responses","volume":"95","author":"Jagla","year":"2019","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0500","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nmeth978","article-title":"A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer","volume":"3","author":"James","year":"2006","journal-title":"Nature Methods"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0505","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.molmet.2017.08.011","article-title":"Decreasing CB(1) receptor signaling in Kupffer cells improves insulin sensitivity in obese mice","volume":"6","author":"Jourdan","year":"2017","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0510","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1124\/mol.104.006882","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?","volume":"67","author":"Kearn","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0515","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0165-6147(00)89032-X","article-title":"Agonist-receptor efficacy. II. Agonist trafficking of receptor signals","volume":"16","author":"Kenakin","year":"1995","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0520","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.tips.2007.06.009","article-title":"Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors","volume":"28","author":"Kenakin","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0525","series-title":"Pharmacology","first-page":"63","article-title":"Chapter 4 - ligand-receptor binding and tissue response","author":"Kenakin","year":"2009"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109844","article-title":"Biased signaling as allosteric probe dependence","volume":"79","author":"Kenakin","year":"2021","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0535","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd3954","article-title":"Signalling bias in new drug discovery: Detection, quantification and therapeutic impact","volume":"12","author":"Kenakin","year":"2013","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0540","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: The impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"Kenakin","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0545","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1021\/cn200111m","article-title":"A simple method for quantifying functional selectivity and agonist bias","volume":"3","author":"Kenakin","year":"2012","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0550","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nrd2838","article-title":"Cellular assays as portals to seven-transmembrane receptor-based drug discovery","volume":"8","author":"Kenakin","year":"2009","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0555","first-page":"294","article-title":"Cannabinoid receptors in the central nervous system: Their signaling and roles in disease","volume":"10","author":"Kendall","year":"2016","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0560","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased Agonism and biased allosteric modulation at the CB1 cannabinoid receptor","volume":"88","author":"Khajehali","year":"2015","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0565","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fendo.2014.00068","article-title":"Allosteric and biased g protein-coupled receptor signaling regulation: Potentials for new therapeutics","volume":"5","author":"Khoury","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0570","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acs.jmedchem.6b01448","article-title":"Pyrimidinyl Biphenylureas: Identification of new Lead compounds as allosteric modulators of the cannabinoid receptor CB(1)","volume":"60","author":"Khurana","year":"2017","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0575","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2015.02.025","article-title":"Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice","volume":"284","author":"Kinden","year":"2015","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0580","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1463-1326.2009.01188.x","article-title":"A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes","volume":"12","author":"Kipnes","year":"2010","journal-title":"Diabetes, Obesity & Metabolism"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0585","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-023-37864-4","article-title":"Structural basis for activation of CB1 by an endocannabinoid analog","volume":"14","author":"Krishna Kumar","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0590","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cell.2018.11.040","article-title":"Structure of a signaling cannabinoid receptor 1-G protein complex","volume":"176","author":"Krishna Kumar","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0595","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"PRESTO-tango as an open-source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze","year":"2015","journal-title":"Nature Structural & Molecular Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0600","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.forsciint.2015.12.046","article-title":"Synthetic cannabinoid drug use as a cause or contributory cause of death","volume":"260","author":"Labay","year":"2016","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0605","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mce.2013.09.035","article-title":"Biased signalling in follicle stimulating hormone action","volume":"382","author":"Landomiel","year":"2014","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0610","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coph.2016.10.005","article-title":"Cannabinoid receptor ligand bias: Implications in the central nervous system","volume":"32","author":"Laprairie","year":"2017","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0615","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1124\/mol.115.101980","article-title":"Biased type 1 cannabinoid receptor signaling influences neuronal viability in a cell culture model of Huntington disease","volume":"89","author":"Laprairie","year":"2016","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0620","doi-asserted-by":"crossref","first-page":"24845","DOI":"10.1074\/jbc.M114.557025","article-title":"Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons","volume":"289","author":"Laprairie","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2019.03.033","article-title":"Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington\u2019s disease in the R6\/2 mouse model","volume":"151","author":"Laprairie","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0630","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1021\/acschemneuro.6b00041","article-title":"Mapping cannabinoid 1 receptor allosteric site(s): Critical molecular determinant and signaling profile of GAT100, a novel, potent, and irreversibly binding probe","volume":"7","author":"Laprairie","year":"2016","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0635","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","article-title":"Enantiospecific allosteric modulation of cannabinoid 1 receptor","volume":"8","author":"Laprairie","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0640","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.mie.2017.06.031","article-title":"Approaches to assess biased signaling at the CB1R receptor","volume":"593","author":"Laprairie","year":"2017","journal-title":"Methods in Enzymology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0645","doi-asserted-by":"crossref","first-page":"19144","DOI":"10.1073\/pnas.0509588102","article-title":"The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\/11 G proteins","volume":"102","author":"Lauckner","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0650","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/1087057109337937","article-title":"Pharmacological characterization of receptor redistribution and beta-arrestin recruitment assays for the cannabinoid receptor 1","volume":"14","author":"van der Lee","year":"2009","journal-title":"Journal of Biomolecular Screening"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0655","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.3390\/molecules26175413","article-title":"CB1 cannabinoid receptor signaling and biased signaling","volume":"26","author":"Leo","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0660","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.bcp.2010.02.015","article-title":"Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin","volume":"79","author":"Leonti","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0665","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.2174\/0929867330666230113125246","article-title":"GPCR Allostery: A view from computational biology","volume":"30","author":"Li","year":"2023","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0670","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1016\/j.cell.2023.11.017","article-title":"Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism","volume":"186","author":"Liao","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0675","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1021\/jm060996+","article-title":"Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- [5-(trifluoromethyl)pyridin-2-yl]oxypropanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity","volume":"49","author":"Lin","year":"2006","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0680","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41401-018-0164-x","article-title":"Translational potential of allosteric modulators targeting the cannabinoid CB(1) receptor","volume":"40","author":"Lu","year":"2019","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0685","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0690","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.bmcl.2013.02.025","article-title":"Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors","volume":"23","author":"Madadi","year":"2013","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0695","doi-asserted-by":"crossref","first-page":"G535","DOI":"10.1152\/ajpgi.00397.2013","article-title":"Inhibitory signaling by CB1 receptors in smooth muscle mediated by GRK5\/beta-arrestin activation of ERK1\/2 and Src kinase","volume":"306","author":"Mahavadi","year":"2014","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0700","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"issue":"Suppl. 8","key":"10.1016\/j.pharmthera.2025.108795_bb0705","first-page":"91","article-title":"Role of endocannabinoids in cardiovascular shock","volume":"59","author":"Malinowska","year":"2008","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0710","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2013.03.032","article-title":"Cannabinoid signaling and liver therapeutics","volume":"59","author":"Mallat","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2016.11.014","article-title":"Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets","volume":"128","author":"Mallipeddi","year":"2017","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008360","article-title":"Astrocyte-mediated spike-timing-dependent long-term depression modulates synaptic properties in the developing cortex","volume":"16","author":"Manninen","year":"2020","journal-title":"PLoS Computational Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108611","article-title":"Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias","volume":"193","author":"Manning","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0730","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12311-014-0629-5","article-title":"Cerebellar endocannabinoids: retrograde signaling from purkinje cells","volume":"14","author":"Marcaggi","year":"2015","journal-title":"Cerebellum"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0735","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0740","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0745","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/26481","article-title":"An analgesia circuit activated by cannabinoids","volume":"395","author":"Meng","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0750","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1124\/pr.110.003491","article-title":"The highs and lows of cannabinoid receptor expression in disease: Mechanisms and their therapeutic implications","volume":"63","author":"Miller","year":"2011","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0755","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ejps.2003.11.010","article-title":"Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors","volume":"21","author":"Milligan","year":"2004","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0760","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jamapsychiatry.2019.0970","article-title":"Measuring disturbance of the endocannabinoid system in psychosis: A systematic review and Meta-analysis","volume":"76","author":"Minichino","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0765","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.phrs.2017.11.019","article-title":"Enantiomer-specific positive allosteric modulation of CB(1) signaling in autaptic hippocampal neurons","volume":"129","author":"Mitjavila","year":"2018","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0770","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/sj.bjp.0706928","article-title":"Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors","volume":"149","author":"Moezi","year":"2006","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0775","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s002109900043","article-title":"Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship","volume":"360","author":"Molderings","year":"1999","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0780","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.mcn.2004.09.004","article-title":"Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase\/AKT signaling","volume":"28","author":"Molina-Holgado","year":"2005","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0785","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050269","article-title":"Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice","volume":"5","author":"Monory","year":"2007","journal-title":"PLoS Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0790","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.neuron.2006.07.006","article-title":"The endocannabinoid system controls key epileptogenic circuits in the hippocampus","volume":"51","author":"Monory","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0795","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1590\/S1516-44462009000200012","article-title":"The psychiatric side-effects of rimonabant","volume":"31","author":"Moreira","year":"2009","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0800","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0805","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson\u2019s disease: Role of CB(1) and TRPV1 receptors","volume":"208","author":"Morgese","year":"2007","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0810","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0815","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymeth.2015.04.010","article-title":"Quantifying biased signaling in GPCRs using BRET-based biosensors","volume":"92","author":"Namkung","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0820","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuron.2008.01.029","article-title":"Endocannabinoids mediate neuron-astrocyte communication","volume":"57","author":"Navarrete","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0825","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bcp.2018.08.046","article-title":"Cannabidiol skews biased agonism at cannabinoid CB(1) and CB(2) receptors with smaller effect in CB(1)-CB(2) heteroreceptor complexes","volume":"157","author":"Navarro","year":"2018","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104940","article-title":"Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB(1), CB(2) and CB(1)\/CB(2) heteromer receptors","volume":"159","author":"Navarro","year":"2020","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0835","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"beta-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner","volume":"71","author":"Nguyen","year":"2012","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0840","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/med.21418","article-title":"Allosteric modulation: An alternate approach targeting the cannabinoid CB1 receptor","volume":"37","author":"Nguyen","year":"2017","journal-title":"Medicinal Research Reviews"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108589","article-title":"Non-canonical G protein signaling","volume":"255","author":"Nurnberg","year":"2024","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0850","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tips.2014.09.010","article-title":"What is biased efficacy? Defining the relationship between intrinsic efficacy and free energy coupling","volume":"35","author":"Onaran","year":"2014","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0855","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0860","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-3-319-20825-1_14","article-title":"Endocannabinoids and the cardiovascular system in health and disease","volume":"231","author":"O\u2019Sullivan","year":"2015","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0865","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1146\/annurev-pharmtox-010818-021441","article-title":"Beyond THC and endocannabinoids","volume":"60","author":"Pacher","year":"2020","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0870","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0875","doi-asserted-by":"crossref","first-page":"D395","DOI":"10.1093\/nar\/gkac1013","article-title":"GPCRdb in 2023: State-specific structure models using AlphaFold2 and new ligand resources","volume":"51","author":"Pandy-Szekeres","year":"2023","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0880","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1523\/JNEUROSCI.22-22-09771.2002","article-title":"Increased severity of stroke in CB1 cannabinoid receptor knock-out mice","volume":"22","author":"Parmentier-Batteur","year":"2002","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0885","doi-asserted-by":"crossref","first-page":"6639","DOI":"10.3390\/ijms21186639","article-title":"A peripheral CB1R antagonist increases lipolysis, oxygen consumption rate, and markers of Beiging in 3T3-L1 adipocytes similar to RIM, suggesting that central effects can be avoided","volume":"21","author":"Paszkiewicz","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109865","article-title":"Biased agonism at the cannabinoid receptors - evidence from synthetic cannabinoid receptor agonists","volume":"78","author":"Patel","year":"2021","journal-title":"Cellular Signalling"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0895","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1157","article-title":"Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor","volume":"11","author":"Patel","year":"2023","journal-title":"Pharmacology Research & Perspectives"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113871","article-title":"Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists","volume":"175","author":"Patel","year":"2020","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0905","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1171870","article-title":"Spinal endocannabinoids and CB1 receptors mediate C-fiber-induced heterosynaptic pain sensitization","volume":"325","author":"Pernia-Andrade","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0910","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0915","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tins.2021.02.001","article-title":"Modulating the neuromodulators: Dopamine, serotonin, and the endocannabinoid system","volume":"44","author":"Peters","year":"2021","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0920","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0925","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15563650.2019.1661425","article-title":"Synthetic cannabinoid receptor agonists: Classification and nomenclature","volume":"58","author":"Potts","year":"2020","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0930","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1124\/mol.105.016162","article-title":"Allosteric modulation of the cannabinoid CB1 receptor","volume":"68","author":"Price","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0935","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bmcl.2015.12.024","article-title":"Biased agonism: An emerging paradigm in GPCR drug discovery","volume":"26","author":"Rankovic","year":"2016","journal-title":"Bioorganic & Medicinal Chemistry Letters"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0940","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bph.13341","article-title":"Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors","volume":"173","author":"Redmond","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0945","series-title":"Beta-arrestin-biased cannabinoid CB1 receptor agonists and methods for making and using them","author":"Reggio","year":"2020"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0950","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03159","article-title":"Cannabinoid-induced actomyosin contractility shapes neuronal morphology and growth","volume":"3","author":"Roland","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0955","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: From molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0960","doi-asserted-by":"crossref","first-page":"46645","DOI":"10.1074\/jbc.M206590200","article-title":"The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1\/B-Raf\/ERK pathway","volume":"277","author":"Rueda","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0965","doi-asserted-by":"crossref","first-page":"10264","DOI":"10.1523\/JNEUROSCI.4171-12.2013","article-title":"Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: Distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions","volume":"33","author":"Ruehle","year":"2013","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116052","article-title":"Investigating selectivity and bias for G protein subtypes and beta-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB(1) receptor","volume":"222","author":"Ryalls","year":"2024","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0975","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/432607","article-title":"Rimonabant: From RIO to ban","volume":"2011","author":"Sam","year":"2011","journal-title":"Journal of Obesity"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0980","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41467-022-34055-5","article-title":"Dynamic spatiotemporal determinants modulate GPCR:G protein coupling selectivity and promiscuity","volume":"13","author":"Sandhu","year":"2022","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0985","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2019.05.006","article-title":"Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR\/transducer selectivity and therapeutic potential","volume":"200","author":"Seyedabadi","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0990","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41589-019-0387-2","article-title":"Structure of an allosteric modulator bound to the CB1 cannabinoid receptor","volume":"15","author":"Shao","year":"2019","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb0995","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature20613","article-title":"High-resolution crystal structure of the human CB1 cannabinoid receptor","volume":"540","author":"Shao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1000","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41591-018-0299-9","article-title":"Cannabinoid CB(1) receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behavior","volume":"25","author":"Shen","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1399-3011.2002.21065.x","article-title":"Activation of the cannabinoid CB1 receptor may involve a W6 48\/F3 36 rotamer toggle switch","volume":"60","author":"Singh","year":"2002","journal-title":"The Journal of Peptide Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2020.00054","article-title":"Positive allosteric modulation of CB(1) cannabinoid receptor signaling enhances morphine Antinociception and attenuates morphine tolerance without enhancing morphine- induced dependence or reward","volume":"13","author":"Slivicki","year":"2020","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence","volume":"84","author":"Slivicki","year":"2018","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrd.2017.229","article-title":"Biased signalling: From simple switches to allosteric microprocessors","volume":"17","author":"Smith","year":"2018","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1025","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tem.2015.09.001","article-title":"Emerging functional divergence of beta-Arrestin isoforms in GPCR function","volume":"26","author":"Srivastava","year":"2015","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1030","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1096\/fj.04-3010fje","article-title":"A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson\u2019s disease","volume":"19","author":"van der Stelt","year":"2005","journal-title":"The FASEB Journal"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1035","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1126\/science.aaz0326","article-title":"Molecular mechanism of biased signaling in a prototypical G protein-coupled receptor","volume":"367","author":"Suomivuori","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","article-title":"Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance","volume":"16","author":"Tam","year":"2012","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1050","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.molmet.2017.06.010","article-title":"Peripheral cannabinoid-1 receptor blockade restores hypothalamic leptin signaling","volume":"6","author":"Tam","year":"2017","journal-title":"Molecular Metabolism"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1055","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.3390\/ijms22136886","article-title":"Cannabinoid receptors in myocardial injury: A brother born to rival","volume":"22","author":"Tang","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1060","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/er.2013-1121","article-title":"Chaperoning G protein-coupled receptors: From cell biology to therapeutics","volume":"35","author":"Tao","year":"2014","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1065","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11682-020-00256-z","article-title":"The interaction between cannabis use and a CB1-related polygenic co-expression index modulates dorsolateral prefrontal activity during working memory processing","volume":"15","author":"Taurisano","year":"2021","journal-title":"Brain Imaging and Behavior"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/molecules25020417","article-title":"Allosteric cannabinoid receptor 1 (CB1) ligands reduce ocular pain and inflammation","volume":"25","author":"Thapa","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(10)60935-X","article-title":"Rimonabant for prevention of cardiovascular events (CRESCENDO): A randomised, multicentre, placebo-controlled trial","volume":"376","author":"Topol","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1080","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1677\/JME-08-0190","article-title":"Signal transduction of the CB1 cannabinoid receptor","volume":"44","author":"Turu","year":"2010","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"Beta-arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1090","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cell.2017.07.009","article-title":"How ligands illuminate GPCR molecular pharmacology","volume":"170","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/37371","article-title":"Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock","volume":"390","author":"Wagner","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1105","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.cell.2022.04.005","article-title":"Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation","volume":"185","author":"Wei","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/mol.113.088880","article-title":"Quantification of ligand bias for clinically relevant beta2-adrenergic receptor ligands: Implications for drug taxonomy","volume":"85","author":"van der Westhuizen","year":"2014","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1021\/acs.jmedchem.8b00875","article-title":"Allosteric modulation of class A GPCRs: Targets, agents, and emerging concepts","volume":"62","author":"Wold","year":"2019","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.08.025","article-title":"Insights into biased signaling at cannabinoid receptors: Synthetic cannabinoid receptor agonists","volume":"169","author":"Wouters","year":"2019","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1130","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acsptsci.9b00069","article-title":"Assessment of biased Agonism among distinct synthetic cannabinoid receptor agonist scaffolds","volume":"3","author":"Wouters","year":"2020","journal-title":"ACS Pharmacology & Translational Science"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-022-00918-y","article-title":"Cannabis suppresses antitumor immunity by inhibiting JAK\/STAT signaling in T cells through CNR2","volume":"7","author":"Xiong","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41589-021-00930-3","article-title":"Structural basis of sphingosine-1-phosphate receptor 1 activation and biased agonism","volume":"18","author":"Xu","year":"2022","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-020-00435-w","article-title":"G protein-coupled receptors: Structure- and function-based drug discovery","volume":"6","author":"Yang","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1150","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1097\/j.pain.0000000000000680","article-title":"Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Abeta-fiber stimulation","volume":"157","author":"Yang","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165973","article-title":"Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases","volume":"1867","author":"Yang","year":"2021","journal-title":"Biochimica et Biophysica Acta - Molecular Basis of Disease"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1874467212666190215112036","article-title":"New insights in cannabinoid receptor structure and signaling","volume":"12","author":"Ye","year":"2019","journal-title":"Current Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1165","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41422-019-0256-2","article-title":"A complex structure of arrestin-2 bound to a G protein-coupled receptor","volume":"29","author":"Yin","year":"2019","journal-title":"Cell Research"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1170","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1038\/s41598-021-90167-w","article-title":"Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor","volume":"11","author":"Zagzoog","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1175","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (GPCRs): Advances in structures, mechanisms, and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1180","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.chempr.2022.12.002","article-title":"DNA-modularized construction of bivalent ligands precisely regulates receptor binding and activation","volume":"9","author":"Zhao","year":"2023","journal-title":"Chem"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1185","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1111\/bph.15066","article-title":"Evaluation of the profiles of CB(1) cannabinoid receptor signalling bias using joint kinetic modelling","volume":"177","author":"Zhu","year":"2020","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108795_bb1190","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human mu-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:07:27Z","timestamp":1777493247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825000075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":238,"alternative-id":["S0163725825000075"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108795","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108795"}}